The Nuvigil and Provigil Pregnancy Registry

C

Cephalon, Inc.

Status

Terminated

Conditions

Shift Work Sleep Disorder
Obstructive Sleep Apnea
Narcolepsy

Treatments

Drug: Modafinil/armodafinil

Study type

Observational

Funder types

Industry

Identifiers

NCT01792583
C10953/9022

Details and patient eligibility

About

The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during pregnancy.

Full description

Both the prospective and the retrospective data are captured.

Enrollment

191 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Reported exposure to brand or generic formulations of Nuvigil (armodafinil) and/or Provigil (modafinil) within 6 weeks prior to becoming pregnant, or during pregnancy
  • Patients who provide oral or written informed consent.
  • Infant up to 1 year of age born to a female with maternal exposure to armodafinil and/or modafinil within 6 weeks prior to becoming pregnant or during pregnancy.
  • Able and willing to provide healthcare professional and secondary contact information, and for the patient herself to be contacted periodically by Registry staff.

Exclusion criteria

  • Patients who refuse to provide oral or written informed consent.
  • Patients not exposed to armodafinil or modafinil within 6 weeks prior to becoming pregnant or during pregnancy.
  • Infants whose mother was not exposed to armodafinil or modafinil within 6 weeks prior to becoming pregnant or during pregnancy.

Trial design

191 participants in 2 patient groups

Prospective Cohort
Description:
Prospective is defined per protocol: prospective data of pregnancy exposure are data acquired prior to the knowledge of the pregnancy outcome or prior to the detection of a congenital malformation at prenatal examination (e.g. fetal ultrasound, serum markers).
Treatment:
Drug: Modafinil/armodafinil
Retrospective Cohort
Description:
Retrospective is defined per protocol: retrospective data of pregnancy exposure are data acquired after the outcome of the pregnancy is known or after the detection of a congenital malformation on prenatal examination.
Treatment:
Drug: Modafinil/armodafinil

Trial contacts and locations

0

Loading...

Central trial contact

Registry Call Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems